MIMEDX offers an array of advanced placental-based allografts that may be used in a variety of dermatological applications.
Product Advantages
- Provides a protective barrier that supports the healing cascade
- Protects the wound bed to aid in the development of granulation tissue
- Provides a biocompatible human extracellular matrix (ECM)
- EPIFIX and EPIEFFECT contain 300+ regulatory proteins1-3
- EPICORD contains 250+ regulatory proteins3-4
- Easy to apply
- Shelf-stable* with a 5-year shelf life
Clinical Areas of Use
- Patients who are not good candidates for skin grafts or flaps
- Incisional repair options are limited
- Cosmetically sensitive areas
PEER REVIEWED RETROSPECTIVE STUDY IN FACIAL PLASTIC SURGERY & AESTHETIC MEDICINE5
This study is the first to compare the outcomes of placental allografts with skin grafts and flaps in the management of complex MMS.
Below are the results of a case-control comparison between placental-based allografts and autologous flap/FTSG treatment.
CONCLUSION
KEY CHALLENGES
Patient Factors
- Thin Skin
- Poor Vascularture/Tissue Quality
- Advanced Age
- Comorbidities
Location
- Scalp
- Ears
- Face/Visible Areas
- Shin or Lower Extremity
- Dorsal Hand
Options For EPIFIX Use
- Secondary intention wound closure
- An alternative for patients that are not candidates for skin grafts or flaps
- Location of wound in high tension area or highly visible
- Patients who decline surgery
CASE EXAMPLES
Basal Cell Carcinoma of the Left Antihelix and Scaphoid Fossa6
REIMBURSEMENT PROGRAMS COMMITTED TO THE SUCCESS OF YOUR TEAM
- 20+ Field Reimbursement Managers
- 20+ Insurance Verification (IVR) Specialists
- Flexible Options for IVR Submission
- Claims Review
- Appeals Support
- Obtain Health Plan Eligibility, Benefits, and Authorizations
- Available for On-Demand Education
PHYSICIAN TESTIMONIALS
WEBINARS
BROCHURES
Mohs Surgery
Casebook
Mohs Patient
Brochure
Mohs Study
Overview Brochure
CARING FOR CHALLENGING CLOSURES WHEN PATIENTS NEED IT MOST.
*See instructions for Use
References
- Koob TJ, et al. J Biomed Mater Res B Appl Biomater. 2014;102(6):1353-1362.
- Lei J, et al. Adv Wound Care (New Rochelle). 2017;6(2):43-53.
- MIMEDX Internal Report. MM-RD-00086.
- Bullard JD, et al. J Biomed Mater Res B Appl Biomater. 2019;107(4):1035-1046.
- Toman J. Facial Plast Surg Aesthet Med. 2022;24(1):48-53.
- Oliver J. Wisco, DO, FAAD, FCMS, Dermatology, Bend, OR.
- Janice Warner, MD, FAAD, FACMS, Dermatology, Austell, GA.